menu
    • menu

    Company profile for GenSight Biologics

    NEW Drugs in Dev: 4
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are an innovative clinical-stage gene therapy company currently focused on discovering, developing and commercializing novel therapies for patients with severe retinal neurodegenerative diseases.Our mission is to turn scientific advances in gene therapy into novel treatments for patients with severe degenerative diseases of the eye and the central nervous system. Our initial focus is on severe retinal diseases, with the goa...
    We are an innovative clinical-stage gene therapy company currently focused on discovering, developing and commercializing novel therapies for patients with severe retinal neurodegenerative diseases.Our mission is to turn scientific advances in gene therapy into novel treatments for patients with severe degenerative diseases of the eye and the central nervous system. Our initial focus is on severe retinal diseases, with the goal of preserving or restoring vision in patients who suffer from sight-threatening ophthalmic diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    GenSight BiologicsFrance Flag
    Country
    Country
    France
    Address
    Address
    74, rue du Faubourg Saint-Antoine 75012 Paris
    Telephone
    Telephone
    +33 1 76 21 72 20
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.gensight-biologics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/gensight-biologics-sa?trk=prof-exp-company-name
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/gensightbio?lang=fr

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GenSight Biologics Releases Combined General Meeting Results
    GenSight Biologics Releases Combined General Meeting Results

    20 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260520115142/en/GenSight-Biologics-Announces-the-Results-of-its-Combined-General-Meeting-of-May-19-2026

    BUSINESSWIRE
    20 May 2026
    Share Share
    GenSight Biologics to Hold Combined General Meeting
    GenSight Biologics to Hold Combined General Meeting

    18 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260518585228/en/GenSight-Biologics-to-Hold-its-Combined-General-Meeting-on-May-19-2026

    BUSINESSWIRE
    18 May 2026
    Share Share
    GenSight Publishes Indirect Comparison of LHON Treatments
    GenSight Publishes Indirect Comparison of LHON Treatments

    11 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7421777

    FIRSTWORD PHARMA
    11 May 2026
    Share Share
    Gensight Biologics Sets Annual General Meeting For May 19, 2026
    Gensight Biologics Sets Annual General Meeting For May 19, 2026

    28 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7232490

    FIRSTWORD PHARMA
    28 Apr 2026
    Share Share
    GenSight Biologics Announces Filing of 2025 Registration Document
    GenSight Biologics Announces Filing of 2025 Registration Document

    15 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260415655171/en/GenSight-Biologics-Announces-the-Filing-of-its-2025-Universal-Registration-Document

    BUSINESSWIRE
    15 Apr 2026
    Share Share
    GenSight Bio Confirms Definitive Full-Year 2025 Financial Results
    GenSight Bio Confirms Definitive Full-Year 2025 Financial Results

    03 Apr 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260403323495/en/GenSight-Biologics-Confirms-Definitive-Full-Year-2025-Consolidated-Financial-Results-Are-in-Line-with-Estimates

    BUSINESSWIRE
    03 Apr 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search